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An in vivo study of voltage-dependent renal tubular acidosis induced by
amiloride. It has been proposed that most forms of hyperkalemic distal
renal tubular acidosis (dRTA) result from a voltage-dependent acidifi-
cation defect in the cortical collecting tubule (CCT) in which hydrogen
and potassium secretion are decreased secondary to a reduced, trans-
epithelial potential difference (PD) arising from impaired sodium reab-
sorption. The present in vivo study examines one model of hyperkale-
mic dRTA, induced by chronic amiloride administration, to examine the
relationship between urinary excretion of hydrogen and potassium ions
and CCT PD in the rat kidney. Chronic administration of amiloride
produced a significant metabolic acidosis with a plasma bicarbonate of
21.3 mmol/liter compared to 25,9 mmol/liter in control rats. Plasma
potassium was higher in experimental animals (4.9 mmol/liter vs. 3.3
mmollliter in controls) and was associated with a significantly reduced
fractional excretion of potassium of 11.2% versus 37.4% in controls.
When animals were loaded with DOCA and infused with 4% sodium
sulphate to maximize urine acidification, urine pH was significantly
higher in the experimental group (6.35 vs. 5.55 in controls) while the
mean PD in cortical collecting tubules was markedly lower at —21.1 mV
versus —58.9 mV in controls. These results support a voltage dependent
mechanism to explain the defect in hydrogen and potassium ion
secretion induced by amiloride.
Hyperkalemic (Type 4) distal renal tubular acidosis (dRTA) is
now a well recognized entity and has been described in associ-
ation with a variety of clinical disorders [1—6]. In addition,
several experimental models of dRTA have been developed and
studied. For example, Arruda and co-workers [7] and others [8—
11] have investigated the effects of amiloride [7], lithium [8, 9]
and ureteric obstruction [10, 11] on renal acidification. Each
model exhibited impaired hydrogen ion excretion with the
development of acidosis, while two of these models [7, 10, 11]
also showed reduced potassium excretion and significant hy-
perkalemia.
Subsequent studies performed in vitro using the turtle blad-
der [12] and toad bladder [131 as amphibian counterparts of the
mammalian distal nephron demonstrated reduced hydrogen ion
secretion following exposure of the bladders to either lithium or
amiloride. Comparisons made between short circuit and open
circuit conditions provided evidence that hydrogen ion secre-
tion was in part voltage dependent. Hence it was proposed that
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most forms of hyperkalemic dRTA result from a voltage depen-
dent defect in distal hydrogen and potassium ion secretion.
According to this proposal, the primary problem is an impair-
ment of sodium reabsorption in the cortical collecting tubule
with a consequent reduction in the magnitude of the normally
negative, transepithelial potential difference (PD) in this seg-
ment. Potassium and hydrogen secretion is thus impaired
secondarily because of a less favorable electrical gradient.
Further support for this theory has been obtained in other
studies using in vitro perfused, isolated cortical collecting
tubules exposed to amiloride [14], lithium [15] or prior ureteric
obstruction [16]. However, so far, no in vivo studies of the
various models of hyperkalemic dRTA have directly examined
the correlation between cortical collecting tubule PD and the
urinary excretion of hydrogen and potassium ions. The present
micropuncture study performed in the chronic amiloride model
of hyperkalemic dRTA examines this correlation in vivo under
conditions favoring maximal urinary acidification, and provides
strong support for a distal voltage-dependent mechanism to
explain the impaired urinary acidification observed in this
model.
Methods
Studies were performed on nine male members (body weight
180 to 350 g) of a locally inbred strain of Ginger-hooded rats
prepared for micropuncture of the left kidney as described
previously [17]. The nine animals were divided into two groups.
Group 1
Four rats were given intraperitoneal amiloride in a dose of 3
mg/kg/day for a minimum of four days prior to experimentation.
In addition, 1.5 mg deoxycorticosterone acetate (DOCA) was
injected intramuscularly 24 and 2 hours prior to each experi-
ment. Free flow transepithelial PD's were measured in cortical
collecting tubules while blood and urine specimens were col-
lected for clearance measurements.
Group 2
Five rats served as a control for Group 1. The protocol was
identical to that of Group 1 except that amiloride was withheld.
Throughout each experiment, C14 inulin (2 jzCi/ml) in Ring-
ers solution (Na 140 mmol/liter, K 5 mmollliter, Cl 115 mmol/
liter, HCO3 30 mmoL/liter) was infused intravenously at a rate of
0.01 ml/min to permit determination of glomerular filtration
rate, while 4% Na2SO4 was infused continuously at 0.033 ml!
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Table 1. Summary of clearance and micropuncture data
Group 1 Group 2 P value
amiloride (A) control (C) A vs. C
GFR mI/mm 2.0 0.1 (8) 2,1 0.2 (8) NS
Plasma Na 143.9 0.8 (10) 145.9 0.8 (12) NS
mmol/ liter
FE Na % 6.6 0.6 (9) 4.8 0.5 (9) NS
Plasma K 4.9 0.3 (8) 3.3 0.1 (10) <0.001
mmol/liter
FE K % 11.2 3.1 (8) 37.4 2.3 (8) <0.001
Plasma HCO3 21.3 1.3 (8) 25.9 1.1 (9) <0.01
mmol/liter
Blood pH 7.26 0.03 (8) 7.34 0.03 (10) NS
Urine pH 6.35 0.07 (8) 5.55 0.05 (10) <0.001
CCT PD mV —21.1 1.9 (26) —58,9 3.1 (28) <0.001
mm to stimulate distal hydrogen secretion. An equilibration
period of 90 minutes was allowed before any collection was
made. In each clearance period a urine sample was collected
under mineral oil in a preweighed sample cup for approximately
20 minutes and urine volume determined gravimetrically. An
arterial blood specimen was collected midway through this
period. After each clearance period, a further urine specimen
was collected under mineral oil into a glass micro-capillary tube
(Corning Medical, Medfield, Massachusetts, USA) and another
blood specimen was collected for gas analysis. Urine samples
were collected from a bladder catheter which was constructed
of polyethylene tubing of outside diameter 1.27 mm (Dural
Plastics Engineering, NSW Australia) but surrounded by a
mineral oil-filled jacket constructed of vinyl tubing (inside
diameter 1.5 mm) to prevent contamination of urine samples by
gas exchange with the atmosphere.
Late distal PD measurements were made using 3 M KC1-filled
microelectrodes of 3 to 5 js external diameter. The electrical
system and techniques for measuring transepithelial PD's in our
laboratory have been described in detail previously [18, 191.
Late distal segments were identified by observing the transit of
a bolus of 0.16% FD & C colored Ringers solution injected into
a proximal tubular segment of the same nephron [18]. These
segments have been shown previously to possess epithelium
characteristic of cortical collecting tubules 118, 19].
Analytical procedures
C 14 inulin activity was measured in ten microliter plasma and
urine samples added to a scintillation cocktail of 10 ml aqueous
counting scintillant (ACS II Amersham, USA) and 0.5 ml
deionized water, and counted in a Packard Liquid Scintillation
Spectrometer.
Plasma and urine specimens were analyzed for Na and K ion
concentrations using a Beckman Klina Flame Photometer
(Beckman Instruments, St. Louis, Missouri, USA). Blood and
urine pH was measured using an Instrumentation Laboratory
513 Blood Gas Analyzer.
Statistical analysis
Differences in means between groups were examined for
significance using standard variance analysis. Values are ex-
pressed as means standard error of the mean.
Control Amiloride
Fig. 1. Distribution of urine pH and transepithelial PD measurements
in cortical collecting tubules for control (Group 2) and amiloride (Group
I) animals, respectively (open circles). Closed circles represent respec-
tive mean values SEM.
Results
The experimental data from both groups are shown in Table
1 and Figure 1.
GFR and electrolytes
Amiloride did not significantly influence GFR, with mean
values of 2.0 0.1 mllmin and 2.1 0.2 mllmin being obtained
in Group 1 experimental rats and Group 2 control rats, respec-
tively. Similarly, neither plasma sodium nor fractiona' excre-
tion of sodium were affected by amiloride pretreatment. In
contrast, Group 1 had a significantly higher mean plasma
potassium of 4.9 0.3 mmol/liter compared to 3.3 0.1 mmol/
liter in Group 2 (P < 0.001) and a lower mean fractional
excretion of potassium of 11.2 3.1% compared to 37.4 2.3%
(P < 0.001; Table 1).
Acidification
Amiloride treated animals had a significantly lower mean
plasma bicarbonate of 21.3 1.3 mmollliter compared to a
value of 25.9 1.1 mmol/liter in control animals (P < 0.01).
Blood pH was also lower in the experimental group, although
the difference was not significant. Urine acidification was
Abbreviations are: FE, fractional excretion; CCT PD, cortical col-
lecting tubule potential difference. Numbers in parentheses are number
of measurements made.
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markedly impaired in the amiloride treated animals, which
produced urine with a mean pH value of 6.35 0.07 compared
to 5.55 0.05 in controls (P < 0.001; Table 1, Fig. 1).
Cortical collecting tubule PDs
Free-flow transepithelial PD's in cortical collecting tubules in
Group 1 experimental animals were significantly lower than in
Group 2 controls. Mean values were —21.1 1.9 mV in Group
1 and —58.9 3.1 mV in Group 2 (P < 0.001; Table 1, Fig. 1).
Discussion
Various experimental models of dRTA have been studied.
These include unilateral ureteric obstruction [10, 11] and the
administration of lithium [8, 9] and amiloride [7]. In each of
these models, impaired urinary acidification was found in
response to an acid stimulus. However, it was noted that
sodium sulphate infusion normalized urine acidification in lith-
ium treated animals but failed to reverse the acidification defect
induced by ureteric obstruction or loading with amiloride.
Based on these results, it was proposed that in the lithium
model, sulphate infusion increased distal sodium delivery,
thereby restoring distal sodium reabsorption and increasing the
magnitude of the negative transepithelial PD existing across
distal nephron segments. This, in turn, provided a more favor-
able gradient for hydrogen ion secretion. In contrast, an acidi-
fication defect persisted during sulphate infusion in the postob-
structive and amiloride models because sodium absorption
remained impaired and the PD across distal segments remained
correspondingly low. Thus, the theory of a voltage dependent
defect in distal hydrogen ion secretion in some types of dRTA
was proposed [7—9, 11].
To further investigate the possible dependency of distal
hydrogen ion secretion on transepithelial voltage, Arruda and
co-workers [121 investigated the effect of lithium on urine
acidification in vitro using the turtle bladder. Lithium had no
effect on acidification when the bladder was maintained in the
short circuited state but did reduce both acidification and
transepithelial PD under open circuited conditions. In other
isolated toad and turtle bladder studies, Ziegler, Fanestil and
Ludens [13] and Arruda et al [7] demonstrated that amiloride
did not alter acidification under short circuit conditions but did
inhibit both potential difference and acidification during open
circuit conditions. In addition, deliberate imposition of a trans-
epithelial voltage across amiloride treated bladders restored
acidification to a rate which was linearly related to the magni-
tude of the PD imposed. Thus, in both lithium- and amiloride-
treated amphibian bladders, acidification was not directly re-
lated to the magnitude of sodium transport but rather to the
magnitude of the transepithelial PD. In subsequent studies
using in vitro perfused rabbit cortical collecting tubules, other
workers have shown that hydrogen ion secretion is significantly
related to the magnitude of the transepithelial PD [14—16].
McKinney and Burg [14] demonstrated that addition of amilo-
ride to the luminal perfusate changed the PD of perfused
cortical collecting tubules from —27.1 mV to +7.0 mV, a
change which was associated with a mean decrease of more
than 50% in total CO2 transport. In another study by Laski and
Kurtzman [15], lithium was shown to reduce both the PD and
total CO2 flux of perfused cortical collecting tubules, while
Campbell, Bello-Reuss and Klahr [16] reported reduced PD's in
perfused cortical collecting tubules obtained from rabbit kid-
neys subjected to prior unilateral ureteric obstruction.
Despite these various in vitro studies supporting a voltage
dependent mechanism for hydrogen ion secretion in the cortical
collecting tubule, an in vivo study investigating correlations
between urinary acidification and cortical collecting tubule PD
has not been reported previously.
In the present rat micropuncture study, we have used the
amiloride model of hyperkalemic dRTA to examine the corre-
lation between urine acidification, potassium excretion and
cortical collecting tubule PD's in the rat kidney in vivo. The
results confirm that chronic amiloride administration to rats
produces an acidification defect manifested by persistence of a
relatively high urine pH even under conditions designed to
stimulate maximally urine acidification. Amiloride treated ani-
mals achieved a minimum mean urine pH of 6.35 compared to
a value of 5.55 in control animals. In addition, fractional
potassium excretion was significantly lower (11.2%) in the
amiloride treated animals compared with controls (37.4%),
while the mean plasma potassium level was significantly higher
in the amiloride group (4.9 mmol/liter vs. 3.3 mmol/liter).
Associated with these findings, the mean transepithelial PD in
surface cortical collecting tubules was —21.1 mV in the amilo-
ride group compared to —58.9 mV in controls, a highly signif-
icant difference.
These data obtained in vivo are thus in accord with those
previously obtained in vitro in amphibian bladders [12, 13] and
perfused rabbit cortical collecting tubules [14—16], and strongly
support the concept of a voltage dependent defect in both
hydrogen and potassium ion secretion in the cortical collecting
tubule to explain the hyperkalemic dRTA regularly induced by
amiloride. In this study, we used urine pH as a measure of distal
acidifying capacity and thereby as an indirect indicator of net
acid excretion [20]. Although it is conceded that urine pH does
not measure total hydrogen excretion and that ammonium
excretion is a more direct measure of renal acid excretion, as
emphasized in a number of studies by Halperin et al and others
[2 1—23], it is also true that variations in ammonium excretion,
like variations in urine pH, can reflect variations in ammonia
production, distal hydrogen ion secretion, or both [21]. Hence,
ammonium excretion measurements would not significantly
alter the conclusion that the data obtained in this study support
the concept of a voltage-dependent acidification defect induced
by amiloride. Whether evidence for such a mechanism exists in
other models of hyperkalemic dRTA is currently being investi-
gated.
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